News About: Pharm. Affairs
109 products including Tamifly selected as National Essential Pharmaceutical Product
109 products, including the novel swine-origin influenza A(H1N1) treatment ‘Tamiflu,’ were selected as the national essential pharmaceutical product, and will be stably supplied.
The government(Office for Government ...
‘Forsteo’ insured in 10 years of commercialization starting from December
The world’s first osteoporosis injection of Lilly Korea(CEO Paul Henry Huibers), ‘Forsteo Inj(generic name: teriparatide)’ has been covered by the National Health Insurance since the 1st of December in accordance with...
Korean pharmas active on developing their own vaccines to increase self-sufficiency
In the Korean vaccine market, which has been taken over by multinational companies, Korean products have started to show up. Even though vaccine development has been very active recently, it was criticized the Korea’s...
About 4,000 animal pharmacies, “We should pay attention to animal drugs”
The Korean Veterinary Pharmacy Association(Chairman Jin-Hyung Lim, KVPA) held the 3rd general meeting, and appointed a pharmacist, Sung-Jin Kim(special commissioner at the veterinary pharmacy division of the Korean Ph...
AI vs. Pharmacist should be differentiated with ‘empathic ability’
Although professionalism of pharmacist has been stressed, an anticipation was made that the job of ‘pharmacist’ will disappear in the future since the role to dispense drugs might be replaced to the artificial intelli...
FTC imposes corrective measures on Boehringer to dispose its animal drugs
Boehringer Ingelheim was given corrective measures to its dispose assets related to sales of its porcine circovirus vaccine and oral nonsteroidal anti-inflammatory drug(NSAID) for use in dogs in Korea.
On the 23rd, t...
Fierce competition expected among hepatitis C therapies, triggered by Zepatier’s approval
Another competitor showed up in the Korean hepatitis C therapy market where Gilead and BMS are competing each other.
According to the industry concerned on the 22nd, the Korea MSD’s hepatitis C therapy ‘Zepatier(elba...
Handok signs agreement to export Ketotop to Singapore and Malaysia with Zuellig
Handok(Chairman Young-Jin Kim) signed a KRW 10 billion agreement to export the patch-type arthritis treatment ‘Ketotop(generic name: ketoprofen)’ to Singapore and Malaysia with the leading distribution company for hea...
BiocurePharm about to release biosimilar for macular degeneration, waiting for patent expiration
From the year of 2018, the price of macular degeneration treatments will significantly drop. This is because the patent of ranibizumab, the main substance of a treatment for macular degeneration, will be expiring in 2...
Will LG Life Sciences & Sanofi’s lawsuit for ‘Zemiglo’ be prolonged?A trial for the Zemiglo’s license between LG Life Sciences and Sanofi Aventis seems to be prolonged.
The Seoul Central District Court’s Civil Affairs Department 17 conducted th...
|
